MICHON BLOWE: Open Payments
NPI 1083091656 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 51 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $1,421
Food & beverage: $1,310Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $456 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $313 |
| Axsome Therapeutics, Inc. | 7 | $258 |
| Teva Pharmaceuticals USA, Inc. | 6 | $189 |
| Otsuka America Pharmaceutical, Inc. | 11 | $177 |
| Lundbeck LLC | 1 | $28 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
